“…[37] In biological systems, PTZs exhibit antioxidant and pro-oxidant effect depending on concentration and availability of reacting radicals, and in particularly Compound 6, due to its ability to exhibit high potency in both simple antioxidant systems and hippocampal slices, has been suggested as a potential therapeutic agent for neurodegenerative disorders and other conditions associated with oxidative stress. [37] TF, promethazine, methotrimeprazine, N-Me-PTZ, and chlorpromazine, Compounds 7, 8, 9, 10, 11, respectively, in Table 1, are all able to significantly inhibit NO consumption in different experimental models. [37] Interestingly, unsubstituted PTZ has shown a 1000-times more potent activity at inhibiting NO, than standard antioxidants such as trolox and edaravone.…”